Capilano Honey Limited’s Stock Mounted on ASX After Release of FY18 Results and Takeover Bid from Private Equity Group

Capilano Honey Limited’s - Kalkine Media

Capilano Honey Limited’s (ASX: CZZ) shares climbed up 25.24 per cent on August 13, 2018 after the announcement of FY18 results and the receipt of takeover bid wherein the group has entered into a Scheme Implementation Agreement with Wattle Hill RHC Fund and ROC Capital Pty Ltd for the total consideration of A$189.8 Mn ($138 Mn). Under the scheme, the CZZ’s shareholders will receive A$20.06 per share cash, which represents a premium of 28.2 per cent to its last closing price.

On the financial front, Revenue from ordinary activities increased by 4 per cent and amounted to $138.5 Mn in FY18 as compared the prior year. It was mainly driven by further gains in revenue and volume in both domestic and export retail sales during the same period. However, NPAT declined by 4.9% (Y-o-Y) to $9.8 Mn in FY18, as no tax was attributable to the capital gain on the asset sale in FY17.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

As a result, Capilano achieved a $1.29 Mn positive cash flow after the impact of further increase to its honey inventory of $7.1 Mn. Net debt rose from $7.8 Mn to $11.4 Mn to fund higher inventory levels in FY18 from the prior year. Based on the robust performance, the group’s financial position remains strong with net assets of $68.3 Mn as of June 30, 2018, up by 5.98 Mn on Y-o-Y basis.

Capilano Honey Limited traded at a market price of $ 19.60 with the market capitalization of circa $148.01 Mn (AEST: 02:30 P.M.).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report